{"id":"https://openalex.org/W3014635003","doi":"https://doi.org/10.1021/acschemneuro.0c00086","title":"Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide cyclo[Pro-Sar-Phe- d -Phe]: A Mixed Opioid Receptor Agonist\u2013Antagonist Following Oral Administration","display_name":"Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide cyclo[Pro-Sar-Phe- d -Phe]: A Mixed Opioid Receptor Agonist\u2013Antagonist Following Oral Administration","publication_year":2020,"publication_date":"2020-04-06","ids":{"openalex":"https://openalex.org/W3014635003","doi":"https://doi.org/10.1021/acschemneuro.0c00086","mag":"3014635003","pmid":"https://pubmed.ncbi.nlm.nih.gov/32251585"},"language":"en","primary_location":{"id":"doi:10.1021/acschemneuro.0c00086","doi":"https://doi.org/10.1021/acschemneuro.0c00086","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acschemneuro.0c00086","pdf_url":null,"source":{"id":"https://openalex.org/S180465690","display_name":"ACS Chemical Neuroscience","issn_l":"1948-7193","issn":["1948-7193"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Chemical Neuroscience","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085960613","display_name":"Michael J. Ferracane","orcid":"https://orcid.org/0000-0002-3007-3126","observed_orcids":["https://orcid.org/0000-0002-3007-3126"]},"institutions":[{"id":"https://openalex.org/I193054373","display_name":"University of Redlands","ror":"https://ror.org/02hfyct53","country_code":"US","type":"education","lineage":["https://openalex.org/I193054373"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Ferracane","raw_affiliation_strings":["Department of Chemistry, University of Redlands, Redlands, California 92373, United States","Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, University of Redlands, Redlands, California 92373, United States","institution_ids":["https://openalex.org/I193054373"]},{"raw_affiliation_string":"Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006945024","display_name":"Ariana C. Brice\u2010Tutt","orcid":"https://orcid.org/0000-0001-6107-2743","observed_orcids":["https://orcid.org/0000-0001-6107-2743"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ariana C. Brice-Tutt","raw_affiliation_strings":["Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050210444","display_name":"Jeremy S. Coleman","orcid":"https://orcid.org/0000-0002-1005-3355","observed_orcids":["https://orcid.org/0000-0002-1005-3355"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy S. Coleman","raw_affiliation_strings":["Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031592630","display_name":"Grant G. Simpson","orcid":"https://orcid.org/0000-0003-1693-7060","observed_orcids":["https://orcid.org/0000-0003-1693-7060"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grant G. Simpson","raw_affiliation_strings":["Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023862403","display_name":"Lisa Wilson","orcid":"https://orcid.org/0000-0001-7770-8726","observed_orcids":["https://orcid.org/0000-0001-7770-8726"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa L. Wilson","raw_affiliation_strings":["Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103895501","display_name":"Shainnel O. Eans","orcid":"https://orcid.org/0009-0004-4995-1410","observed_orcids":["https://orcid.org/0009-0004-4995-1410"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shainnel O. Eans","raw_affiliation_strings":["Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000012567","display_name":"Heather M. Stacy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather M. Stacy","raw_affiliation_strings":["Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049838876","display_name":"Thomas F. Murray","orcid":"https://orcid.org/0000-0001-8521-4507","observed_orcids":["https://orcid.org/0000-0001-8521-4507"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas F. Murray","raw_affiliation_strings":["Department of Pharmacology, School of Medicine, Creighton University, Omaha, Nebraska 68178, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, School of Medicine, Creighton University, Omaha, Nebraska 68178, United States","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027117921","display_name":"Jay P. McLaughlin","orcid":"https://orcid.org/0000-0001-9851-9342","observed_orcids":["https://orcid.org/0000-0001-9851-9342"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jay P. McLaughlin","raw_affiliation_strings":["Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022713557","display_name":"Jane V. Aldrich","orcid":"https://orcid.org/0000-0002-7954-9850","observed_orcids":["https://orcid.org/0000-0002-7954-9850"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jane V. Aldrich","raw_affiliation_strings":["Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States"],"raw_orcid":"https://orcid.org/0000-0002-7954-9850","affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States","institution_ids":["https://openalex.org/I33213144"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5022713557"],"corresponding_institution_ids":["https://openalex.org/I33213144"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":0.8292,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.67652146,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":98},"biblio":{"volume":"11","issue":"9","first_page":"1324","last_page":"1336"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.9326000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.9326000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.06080000102519989,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kappa-opioid-receptor","display_name":"kappa opioid receptor","score":0.6600000262260437},{"id":"https://openalex.org/keywords/substance-abuse","display_name":"substance abuse","score":0.4699999988079071},{"id":"https://openalex.org/keywords/cocaine-conditioned-place-preference","display_name":"cocaine conditioned place preference","score":0.9110000133514404},{"id":"https://openalex.org/keywords/reinstatement","display_name":"reinstatement","score":0.6190000176429749},{"id":"https://openalex.org/keywords/antinociception","display_name":"antinociception","score":0.8809999823570251},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9369999766349792},{"id":"https://openalex.org/keywords/peptide-conformation","display_name":"peptide conformation","score":0.8270000219345093},{"id":"https://openalex.org/keywords/intramolecular-hydrogen-bonding","display_name":"intramolecular hydrogen bonding","score":0.9710000157356262},{"id":"https://openalex.org/keywords/opioid-analgesics","display_name":"opioid analgesics","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C2779564779","wikidata":"https://www.wikidata.org/wiki/Q7706647","display_name":"Tetrapeptide","level":3,"score":0.8972926139831543},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7760269641876221},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5627343654632568},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5536622405052185},{"id":"https://openalex.org/C35124327","wikidata":"https://www.wikidata.org/wiki/Q5159285","display_name":"Conditioned place preference","level":3,"score":0.49131980538368225},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4888295531272888},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.45148923993110657},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.45001617074012756},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.44593292474746704},{"id":"https://openalex.org/C2779809887","wikidata":"https://www.wikidata.org/wiki/Q14864278","display_name":"Peptide synthesis","level":3,"score":0.42869511246681213},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4238373637199402},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17672333121299744},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1313435137271881}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010456","descriptor_name":"Peptides, Cyclic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017473","descriptor_name":"Receptors, Opioid, kappa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017473","descriptor_name":"Receptors, Opioid, kappa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017473","descriptor_name":"Receptors, Opioid, kappa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/acschemneuro.0c00086","doi":"https://doi.org/10.1021/acschemneuro.0c00086","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acschemneuro.0c00086","pdf_url":null,"source":{"id":"https://openalex.org/S180465690","display_name":"ACS Chemical Neuroscience","issn_l":"1948-7193","issn":["1948-7193"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Chemical Neuroscience","raw_type":"journal-article"},{"id":"pmid:32251585","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32251585","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS chemical neuroscience","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8560000061988831}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8999999761581421}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2050214382","display_name":null,"funder_award_id":"R01-DA023924","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G2638237065","display_name":"Acquisition of a Q Exactive HF Hybrid Quadrupole-Orbitrap","funder_award_id":"1s10od021758-01a1","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G4020899462","display_name":"Peptidic Kappa Opioid Receptor Ligands as Potential Treatments for Drug Addiction","funder_award_id":"5r01da023924-10","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G6015332917","display_name":null,"funder_award_id":"W81XWH-15-1-0452","funder_id":"https://openalex.org/F4320332201","funder_display_name":"Office of the Secretary of Defense"},{"id":"https://openalex.org/G7429546739","display_name":null,"funder_award_id":"W81XWH-15-1-0464","funder_id":"https://openalex.org/F4320332201","funder_display_name":"Office of the Secretary of Defense"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332201","display_name":"Office of the Secretary of Defense","ror":"https://ror.org/00q4sx826"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W1490153810","https://openalex.org/W1513558481","https://openalex.org/W1566369503","https://openalex.org/W1575043539","https://openalex.org/W1593555249","https://openalex.org/W1888470382","https://openalex.org/W1949436941","https://openalex.org/W1974364485","https://openalex.org/W1979046104","https://openalex.org/W1980693070","https://openalex.org/W1985000617","https://openalex.org/W1992787959","https://openalex.org/W2006614558","https://openalex.org/W2009619105","https://openalex.org/W2011852927","https://openalex.org/W2013501854","https://openalex.org/W2022566356","https://openalex.org/W2023924110","https://openalex.org/W2027012753","https://openalex.org/W2031127450","https://openalex.org/W2032643119","https://openalex.org/W2034443934","https://openalex.org/W2048921553","https://openalex.org/W2050148115","https://openalex.org/W2054092950","https://openalex.org/W2054813038","https://openalex.org/W2062978622","https://openalex.org/W2067299901","https://openalex.org/W2079946171","https://openalex.org/W2089035556","https://openalex.org/W2096755381","https://openalex.org/W2105130852","https://openalex.org/W2113394162","https://openalex.org/W2114021405","https://openalex.org/W2116485956","https://openalex.org/W2124391212","https://openalex.org/W2136359146","https://openalex.org/W2146088099","https://openalex.org/W2171367696","https://openalex.org/W2206043426","https://openalex.org/W2275331720","https://openalex.org/W2329429931","https://openalex.org/W2510273208","https://openalex.org/W2808792445","https://openalex.org/W2950303407","https://openalex.org/W3004492296","https://openalex.org/W3036040978","https://openalex.org/W4242341673"],"related_works":["https://openalex.org/W2898845293","https://openalex.org/W2059977717","https://openalex.org/W1968383278","https://openalex.org/W227016627","https://openalex.org/W2012429930","https://openalex.org/W2554746688","https://openalex.org/W1995941521","https://openalex.org/W1981480630","https://openalex.org/W1994598881","https://openalex.org/W1999967901"],"abstract_inverted_index":{"Substance":[0],"abuse":[1],"remains":[2],"a":[3,116,147,179,192],"serious":[4],"public":[5],"health":[6],"crisis,":[7],"affecting":[8],"millions":[9],"of":[10,30,64,91,137,165,199],"people":[11],"worldwide.":[12],"Macrocyclic":[13],"tetrapeptides":[14],"like":[15],"CJ-15,208":[16],"and":[17,60,88,104,135,162,167,177],"[":[18],"d":[19,71,157,189],"-Trp]CJ-15,208":[20],"demonstrate":[21],"opioid":[22,139],"activity":[23],"shown":[24],"to":[25,73,184],"attenuate":[26],"the":[27,49,54,65,197],"rewarding":[28],"effects":[29],"cocaine":[31,166],"in":[32,37,112,119,146,172],"conditioned":[33,169],"place":[34,170],"preference":[35,171],"assays":[36],"mice,":[38],"making":[39],"them":[40],"promising":[41,193],"lead":[42,194],"compounds":[43],"for":[44,196],"treating":[45],"substance":[46,200],"abuse.":[47,201],"In":[48],"present":[50],"study,":[51],"we":[52],"report":[53],"rational":[55],"design,":[56],"synthesis,":[57,96],"conformational":[58],"analysis,":[59],"continued":[61],"pharmacological":[62],"evaluation":[63],"novel":[66],"macrocyclic":[67,93],"tetrapeptide":[68],"cyclo":[69,155,187],"[Pro-Sar-Phe-":[70,156,188],"-Phe]":[72,158,190],"further":[74],"explore":[75],"this":[76],"unique":[77],"molecular":[78,105],"scaffold.":[79],"This":[80],"peptide":[81,108,129],"was":[82],"rationally":[83],"designed":[84],"based":[85],"on":[86],"X-ray":[87],"NMR":[89,103],"structures":[90],"related":[92],"tetrapeptides.":[94],"Following":[95],"its":[97],"solution-phase":[98],"conformations":[99,111],"were":[100],"determined":[101],"by":[102,124],"modeling.":[106],"The":[107,128],"adopted":[109],"multiple":[110],"polar":[113],"solvents,":[114],"but":[115],"single":[117],"conformation":[118],"chloroform":[120],"that":[121],"is":[122,130,191],"stabilized":[123],"intramolecular":[125],"hydrogen":[126],"bonding.":[127],"orally":[131],"bioavailable,":[132],"producing":[133],"antinociception":[134],"antagonism":[136],"kappa":[138],"receptor":[140],"(KOR)":[141],"stimulation":[142],"following":[143,174],"oral":[144,175],"administration":[145],"mouse":[148],"55":[149],"\u00b0C":[150],"warm-water":[151],"tail-withdrawal":[152],"assay.":[153],"Notably,":[154],"blocked":[159],"both":[160],"stress-":[161],"drug-induced":[163],"reinstatement":[164],"morphine":[168],"mice":[173],"administration,":[176],"displayed":[178],"decreased":[180],"side-effect":[181],"profile":[182],"compared":[183],"morphine.":[185],"Thus,":[186],"compound":[195],"treatment":[198]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2020-04-10T00:00:00"}